Management of primary low-grade serous ovarian carcinoma: are you up-to-date on the most contemporary prognostic factors and treatment strategies?

Editor’s Choice: Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survivalEditorial: Low grade serous ovarian cancer: Unpicking drivers of outcomeHosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic OncologyFeaturing:David M. Gershenson, MD, The University of Texas MD Anderson Cancer CenterCharlie Gourley, MD, Nicola Murray Centre for Ovarian Cancer ResearchCheck out more content on the journal's homepage  at https://www.gynecologiconcology-online.net